Schedule 13D ownership disclosure
SPECTRUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 84763A108
Event date: 2018-07-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,988,879
- Percent of class
- 4.6700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171520-18-000354
- Form type
- SC 13D
- Filer
- SHROTRIYA RAJESH C MD
- CIK
- CIK 1193918
- Filed
- Jul 31, 2018
- Reporting period
- Jul 30, 2018
- Description
- Schedule 13D beneficial ownership